|
|
Evalve Announces Initiation of Pivotal Trial of Percutaneous Alternative to Open-Heart Mitral Valve Surgery.
- Article from:
-
PR Newswire
- Article date:
-
October 17, 2005
|
Copyright informationCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Patient Randomization Initiated in Nationwide Trial to Demonstrate MitraClip(TM) Performance for Treatment of Mitral Regurgitation
Positive One-Year Follow-Up Data from EVEREST I Trial presented at TCT Conference Highlights Potential Durability of MitraClip Repair
MENLO PARK, Calif. and WASHINGTON, Oct. 17 /PRNewswire/ -- Evalve, Inc. today announced the successful initiation of the pivotal study, Endovascular Valve Edge-to-Edge REpair STudy (EVEREST) II, a randomized, multi-center study designed to demonstrate the safety and efficacy of its MitraClip(TM) percutaneous valve repair system for patients with mitral regurgitation (MR). EVEREST II will compare the MitraClip ...